Richard W. Paul & Associates »

Intellia Therapeutics shares owned by Richard W. Paul & Associates

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Richard W. Paul & Associates from 13F filings

Historical chart of Richard W. Paul & Associates investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Richard W. Paul & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Richard W. Paul & Associates

Quarter filed Position value Share count Share price at filing
2024-06-30 $45 2 22.50
2024-03-31 $55 2 27.50
2023-12-31 $61 2 30.50
2023-09-30 $63 2 31.50
2023-06-30 $163 4 40.75
2023-03-31 $373 10 37.30
2022-12-31 $349 10 34.90

More positions owned by Richard W. Paul & Associates

Ishares Tr Core S&p Us Gwt (IUSG)
Ishares Tr Core S&p Us Vlu (IUSV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Core Msci Emkt (IEMG)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Richard W. Paul & Associates

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Group
Deep Track Capital
State Street Corporation
Wellington Management Company
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Morgan Stanley
Federated Investors
Geode Capital Management
FMR
Casdin Capital
Alliancebernstein
Contrarius Investment Management

View all funds holding Intellia Therapeutics